The First-Ever Antibiotic Alternative to Move Into Phase 3 Clinical Trials—Vincent A. Fischetti—The Fischetti Lab at Rockefeller University — FutureTech Podcast — Overcast

Overcast Podcaster Info Ads Log In

FutureTech Podcast

The First-Ever Antibiotic Alternative to Move Into Phase 3 Clinical Trials—Vincent A. Fischetti—The Fischetti Lab at Rockefeller University

November 21, 2019

0:00 -:--

Speed

–1×+++++2×+

Website • Share link • Share link with timestamp